Patents by Inventor David W. Wendell

David W. Wendell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11981948
    Abstract: Described herein are engineered organelles comprising multi-component proteins from different species incorporated into a membrane structure with interior and exterior aspects. In one embodiment the artificial organelle incorporates one or more protein complexes that absorb optical energy and catalyze electron transfer in biochemical reactions that can be used to reduce NAD+ to NADH or analogues thereof.
    Type: Grant
    Filed: November 2, 2022
    Date of Patent: May 14, 2024
    Assignee: Ensovi, Inc.
    Inventors: Kyle A Minor, Carlo D. Montemagno, David W. Wendell
  • Publication number: 20240068003
    Abstract: Described herein are engineered organelles comprising multi-component proteins from different species incorporated into a membrane structure with interior and exterior aspects. In one embodiment the artificial organelle incorporates one or more protein complexes that absorb optical energy and catalyze electron transfer in biochemical reactions that can be used to reduce NAD+ to NADH or analogues thereof.
    Type: Application
    Filed: September 21, 2023
    Publication date: February 29, 2024
    Inventors: Kyle A. Minor, Carlo D. Montemagno, David W. Wendell
  • Publication number: 20230212632
    Abstract: Described herein are engineered organelles comprising multi-component proteins from different species incorporated into a membrane structure with interior and exterior aspects. In one embodiment the artificial organelle incorporates one or more protein complexes that absorb optical energy and catalyze electron transfer in biochemical reactions that can be used to reduce NAD+ to NADH or analogues thereof.
    Type: Application
    Filed: November 2, 2022
    Publication date: July 6, 2023
    Inventors: Kyle A. Minor, Carlo D. Montemagno, David W. Wendell
  • Patent number: 11535880
    Abstract: Described herein are engineered organelles comprising multi-component proteins from different species incorporated into a membrane structure with interior and exterior aspects. In one embodiment the artificial organelle incorporates one or more protein complexes that absorb optical energy and catalyze electron transfer in biochemical reactions that can be used to reduce NAD+ to NADH or analogues thereof.
    Type: Grant
    Filed: January 7, 2021
    Date of Patent: December 27, 2022
    Assignee: ENSOVI, INC.
    Inventors: Kyle A. Minor, Carlo D. Montemagno, David W. Wendell
  • Publication number: 20210214762
    Abstract: Described herein are engineered organelles comprising multi-component proteins from different species incorporated into a membrane structure with interior and exterior aspects. In one embodiment the artificial organelle incorporates one or more protein complexes that absorb optical energy and catalyze electron transfer in biochemical reactions that can be used to reduce NAD+ to NADH or analogues thereof.
    Type: Application
    Filed: January 7, 2021
    Publication date: July 15, 2021
    Inventors: Kyle A. Minor, Carlo D. Montemagno, David W. Wendell